Not admitted · Vague or promotional

Opening of a post on the FDA's complete response letter for the Lykos/MAPS MDMA-assisted therapy application. The author says the FDA, as part of a push toward transparency, is moving to release more CRLs publicly.

No entity, observable event, benchmark or threshold can be written from the text and its immediate context. Slogans ('game changer', 'once-in-a-lifetime opportunity', 'favourite stock') and quantifiers with no countable set ('more', 'first', 'all') without a defined set.